Search
Enter keywords, a title or a report id number below.
Your Search for 'China Monoclonal Antibody Industry Report, 2010-2011' returned 32 results - Page 1 of 2
Sort by
Sorted by
Rank
Top-Bottom
-
Global and Chinese Monoclonal Antibody Industry Report, 2013
Research In China, Jan 2013 , Pages: 1002011) Listed Companies Investing in Monoclonal Antibody Industry in China, 2009-2012 Major M&A Cases of Roche, 1990-2010 Revenue and Operating Income of Roche, 2008-2012 Revenue of Roche by Business ... -
Global and Chinese Monoclonal Antibody Industry Report, 2013
Research In China, Jan 2013 , Pages: 1002011) Listed Companies Investing in Monoclonal Antibody Industry in China, 2009-2012 Major M&A Cases of Roche, 1990-2010 Revenue and Operating Income of Roche, 2008-2012 Revenue of Roche by Business ... -
China Genetic Engineering Drug Industry Report, 2011-2012
Research In China, Jul 2012 , Pages: 72World Monoclonal Antibody Drugs Approved for Marketing in China, As of 2012 Sales of Monoclonal Antibody Drugs in China, 2008-2011 Some Listed Companies Investing in Monoclonal Antibody Industry in China ... -
China Genetic Engineering Drug Industry Report, 2011-2012
Research In China, Jul 2012 , Pages: 72World Monoclonal Antibody Drugs Approved for Marketing in China, As of 2012 Sales of Monoclonal Antibody Drugs in China, 2008-2011 Some Listed Companies Investing in Monoclonal Antibody Industry in China ... -
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
GBI Research, Jul 2012 , Pages: 82), interferon-a, interferon-beta, insulin and insulin analogs, monoclonal antibodies (mAbs) and tumor Necrosis Factor-a (TNF-a). The report also includes insights into the biobetter therapeutics R&D pipeline. It ... -
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017
Markets and Markets, Mar 2013 , Pages: 148market. Diagnostics is another segment in focus; monoclonal antibodies are being used extensively in diagnostics and in assays for research. The report also profiles leading participants of the industry ... -
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth
GBI Research, Oct 2012 , Pages: 82Funding Create an Environment Conducive to Growth”. The report provides an analysis of biopharmaceuticals approved in 2010 and 2011, operating dynamics in the biopharmaceutical industry, the current ... -
Taking Advantage of Protein-Based Therapy Opportunities
Decision Resources, Inc, Mar 2011 , Pages: 32. This report examines recombinant protein therapies that are not monoclonal-antibody-based therapies. Questions answered in this report: - Therapeutic proteins are one of the more lucrative sectors of ... -
Big Pharma’s New Licensing Strategies
Decision Resources, Inc, Oct 2011opportunities of importance to the industry and analyze the strategies that companies are using to take advantage of those opportunities. Questions answered in this report: - Biologics markets are growing ... -
Global and China Biopharmaceutical Industry Report, 2010
Research In China, Sep 2010 , Pages: 121Global and China Biopharmaceutical Industry Report, 2010 In recent years, biopharmaceutical industry has been the fastest growing sector in the global pharmaceutical industry. From 1998 to 2009, the ... -
Global and China Biopharmaceutical Industry Report, 2010
Research In China, Sep 2010 , Pages: 121Global and China Biopharmaceutical Industry Report, 2010 In recent years, biopharmaceutical industry has been the fastest growing sector in the global pharmaceutical industry. From 1998 to 2009, the ... -
Global Protein Therapeutics Market Analysis
RNCOS E-Services Private Limited, Jul 2011 , Pages: 180- Monoclonal Antibodies Market (Billion US$), 2010 & 2011 Figure 3-2: Global - Monoclonal Antibodies Market by Segment (%), 2010 Figure 3-3: Global - Use of Monoclonal Antibodies in Cancer Treatment (Billion US ... -
PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
Cambridge Healthtech Institute, Jun 2012&D Investments by Research-Based Pharmaceutical Companies (PhRMA), 1975-2010 Industry-wide and Government R&D Spending, 1980-2011 Biopharmaceutical Industry Investment in Research and Development ... -
Global Monoclonal Antibody Market Analysis
RNCOS E-Services Private Limited, Nov 2010 , Pages: 80the drug approvals received, and no generics for biological therapies have driven the optimistic market performance of this industry. According to our new research report “Global Monoclonal Antibody ... -
Immunochemicals - Global Strategic Business Report
Global Industry Analysts, Inc, Apr 2012 , Pages: 633Immunochemical Test II-23 Amgen Introduces Vectibix II-23 Trevigen Introduces Mouse Monoclonal Antibody II-23 6. RECENT INDUSTRY ACTIVITY II-24 Abcam Takes Over MitoSciences II-24 Rockland Immunochemicals ... -
Cancer Therapies - Global Strategic Business Report
Global Industry Analysts, Inc, Oct 2011 , Pages: 897drugs that were launched the recent years hold a higher price tag, promising substantial revenue growth for the market in the years to come. As stated by Global Industry Analysts's market research report ... -
China Pharmaceutical Market Overview
Datamonitor, Nov 2010 , Pages: 244Administration for Industry and Commerce China's healthcare reform China healthcare reform, 2010-2020 "The Glorious Ten"? China - Health insurance China - Social health insurance The introduction of the urban ... -
Global Protein Therapeutics Market Forecast to 2015
RNCOS E-Services Private Limited, Apr 2012 , Pages: 1607.7 Amgen Inc. 7.8 Pfizer 7.9 Abbott Laboratories 7.10 Novo Nordisk List of Tables Table 4-1: Global - Key Players and Drugs in Monoclonal Antibody Market (Billion US$), 2011 Table 4-2: US - Sales ... -
Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment
GBI Research, Oct 2012 , Pages: 176promising molecules including AIN457, tofacitinib, CF101 and anti-CD6 monoclonal antibody, which are currently in development and are expected to be launched by 2014. Additionally, the report highlights the ... -
The 2011-2016 Outlook for Monoclonal Antibody (MAb)-Based Products in Greater China
ICON Group International, Jan 2011 , Pages: 142The 2011-2016 Outlook for Monoclonal Antibody (MAb)-Based Products in Greater China WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
